Matches in SemOpenAlex for { <https://semopenalex.org/work/W2185989846> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2185989846 endingPage "789" @default.
- W2185989846 startingPage "786" @default.
- W2185989846 abstract "Shivering is a frequent postanaesthetic complication. Its definite reason is unknown. Patients with cardiovascular or pulmonary diseases are endangered by postanaesthetic shivering. The aim of this study was to assess the efficacy of nefopam in prophylaxis of shivering. Additionally we investigated the influence of nefopam on haemodynamic parameters and on the time until extubation.30 patients (ASA I-II) were randomly allocated in a double-blind fashion to one of two groups to receive directly after the end of isoflurane application either nefopam (0.15 mg/kg) or placebo (0.9% saline). The period of anaesthesia had to be longer than 60 minutes. All patients received a premedication with lorazepam (0.02 mg/kg) 30-45 minutes prior to surgery. Induction of anaesthesia was standardised: fentanyl (3 micrograms/kg), thiopentone (5 mg/kg), atracurium (0.4 mg/kg). Intraoperatively a mixture of isoflurane, nitrous oxide (60%) and oxygen was used to maintain anaesthesia. The following parameters were evaluated: Age, sex, duration of operation and anaesthesia and the time between the end of application of volatiles and extubation. Heart rate (HR), mean arterial blood pressure (MAP), rectal temperature and O2-saturation were measured at predefined data points. Postoperatively the consumption of analgesic was documented. The severity of shivering was classified in five grades.In the control-group nine patients shivered (60%), whereas in the nefopam group only one patient (6.6%) shivered (p < 0.05). In comparison to the placebo group we observed in the nefopam group a significantly decreased HR 30 and 60 minutes postoperatively (p < or = 0.007 and p < or = 0.002). We did not observe prolonged awakening in the nefopam-treated patients. MAP and O2-saturation showed similar reactions in both groups.The data indicate that prophylactic administration of nefopam can suppress postanaesthetic shivering. Prolonged awakening was not observed." @default.
- W2185989846 created "2016-06-24" @default.
- W2185989846 creator A5008584646 @default.
- W2185989846 creator A5019190692 @default.
- W2185989846 creator A5027036101 @default.
- W2185989846 creator A5027617085 @default.
- W2185989846 creator A5037860269 @default.
- W2185989846 creator A5038599600 @default.
- W2185989846 creator A5065888034 @default.
- W2185989846 date "1998-12-01" @default.
- W2185989846 modified "2023-09-27" @default.
- W2185989846 title "Prophylaktische Nefopamgabe schützt vor postanästhetischem Shivering" @default.
- W2185989846 doi "https://doi.org/10.1055/s-2007-994854" @default.
- W2185989846 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9893913" @default.
- W2185989846 hasPublicationYear "1998" @default.
- W2185989846 type Work @default.
- W2185989846 sameAs 2185989846 @default.
- W2185989846 citedByCount "9" @default.
- W2185989846 countsByYear W21859898462015 @default.
- W2185989846 countsByYear W21859898462023 @default.
- W2185989846 crossrefType "journal-article" @default.
- W2185989846 hasAuthorship W2185989846A5008584646 @default.
- W2185989846 hasAuthorship W2185989846A5019190692 @default.
- W2185989846 hasAuthorship W2185989846A5027036101 @default.
- W2185989846 hasAuthorship W2185989846A5027617085 @default.
- W2185989846 hasAuthorship W2185989846A5037860269 @default.
- W2185989846 hasAuthorship W2185989846A5038599600 @default.
- W2185989846 hasAuthorship W2185989846A5065888034 @default.
- W2185989846 hasConcept C126838900 @default.
- W2185989846 hasConcept C141071460 @default.
- W2185989846 hasConcept C142724271 @default.
- W2185989846 hasConcept C204787440 @default.
- W2185989846 hasConcept C27081682 @default.
- W2185989846 hasConcept C2776359302 @default.
- W2185989846 hasConcept C2777953023 @default.
- W2185989846 hasConcept C2778300832 @default.
- W2185989846 hasConcept C2780820201 @default.
- W2185989846 hasConcept C2781072394 @default.
- W2185989846 hasConcept C2781258859 @default.
- W2185989846 hasConcept C42219234 @default.
- W2185989846 hasConcept C71924100 @default.
- W2185989846 hasConcept C84393581 @default.
- W2185989846 hasConceptScore W2185989846C126838900 @default.
- W2185989846 hasConceptScore W2185989846C141071460 @default.
- W2185989846 hasConceptScore W2185989846C142724271 @default.
- W2185989846 hasConceptScore W2185989846C204787440 @default.
- W2185989846 hasConceptScore W2185989846C27081682 @default.
- W2185989846 hasConceptScore W2185989846C2776359302 @default.
- W2185989846 hasConceptScore W2185989846C2777953023 @default.
- W2185989846 hasConceptScore W2185989846C2778300832 @default.
- W2185989846 hasConceptScore W2185989846C2780820201 @default.
- W2185989846 hasConceptScore W2185989846C2781072394 @default.
- W2185989846 hasConceptScore W2185989846C2781258859 @default.
- W2185989846 hasConceptScore W2185989846C42219234 @default.
- W2185989846 hasConceptScore W2185989846C71924100 @default.
- W2185989846 hasConceptScore W2185989846C84393581 @default.
- W2185989846 hasIssue "12" @default.
- W2185989846 hasLocation W21859898461 @default.
- W2185989846 hasLocation W21859898462 @default.
- W2185989846 hasOpenAccess W2185989846 @default.
- W2185989846 hasPrimaryLocation W21859898461 @default.
- W2185989846 hasRelatedWork W1521644880 @default.
- W2185989846 hasRelatedWork W1963499254 @default.
- W2185989846 hasRelatedWork W2033470458 @default.
- W2185989846 hasRelatedWork W2080043233 @default.
- W2185989846 hasRelatedWork W2128101747 @default.
- W2185989846 hasRelatedWork W2185989846 @default.
- W2185989846 hasRelatedWork W2247469581 @default.
- W2185989846 hasRelatedWork W2388812944 @default.
- W2185989846 hasRelatedWork W2408698430 @default.
- W2185989846 hasRelatedWork W56975623 @default.
- W2185989846 hasVolume "33" @default.
- W2185989846 isParatext "false" @default.
- W2185989846 isRetracted "false" @default.
- W2185989846 magId "2185989846" @default.
- W2185989846 workType "article" @default.